Imidazopyrimidinones and uses thereof

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/519 (2006.01) A61P 31/18 (2006.01)

Patent

CA 2729656

The present invention provides a compound of formula (I) or a pharmaceutically acceptable derivative, salt or prodrug thereof. The present invention further provides a method of treatment or prophylaxis of a viral infection in a subject compris-ing administering to said subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable derivative, salt or prodrug thereof. Pharmaceutical compositions comprising a compound of formula (I) are also provided.

La présente invention concerne un composé de la formule (I) ou un dérivé, un sel ou un promédicament pharmaceutiquement acceptable de celui-ci. La présente invention concerne en outre une méthode de traitement ou de prophylaxie dune infection virale chez un sujet, laquelle comprend ladministration audit sujet dune quantité efficace dun composé de la formule (I) ou dun dérivé, dun sel ou dun promédicament pharmaceutiquement acceptable de celui-ci. Linvention concerne également des compositions pharmaceutiques qui comprennent un composé de la formule (I).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Imidazopyrimidinones and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazopyrimidinones and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyrimidinones and uses thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1774662

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.